|
Dr. Kimball has 25 years experience in the discovery and development of small molecule drug candidates. He was most recently Vice President, Medicinal Chemistry at Lexicon Pharmaceuticals in Princeton, NJ, beginning in 2001. While at Lexicon, Dr. Kimball was responsible for building an organization of over 75 chemists, including medicinal, analytical, computational, process research and development, library synthesis and outsourcing chemistry. Lexicon Pharmaceuticals’ small molecule pipeline was derived from applying this chemistry capability to the novel drug targets discovered by its genetics platform.
Dr. Kimball spent the 19 years prior to Lexicon at Bristol-Myers Squibb Pharmaceutical Research Institute, most recently as Research Fellow in the Division of Medicinal Chemistry, Princeton, NJ. During his tenure at BMS, he led several significant drug discovery and development research efforts that culminated in clinical compounds.
Dr. Kimball has lectured widely on drug discovery and has been an Associate Member of the Graduate Faculty at Rutgers University School of Pharmacy since 1989. He holds a Ph.D. in Organic Chemistry/Chemical Biology from the State University of New York at Stony Brook. Dr. Kimball joined Pharmacopeia in September of 2007.
| 